528 related articles for article (PubMed ID: 16815602)
1. Prevalence of antibodies to measles and rubella in Sana'a, Yemen.
Sallam TA; Al-Jaufy AY; Al-Shaibany KS; Ghauth AB; Best JM
Vaccine; 2006 Sep; 24(37-39):6304-8. PubMed ID: 16815602
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen.
Sallam TA; Raja'a YA; Benbrake MS; Al-Shaibani KS; Al-Hababi AA
East Mediterr Health J; 2003; 9(1-2):148-51. PubMed ID: 15562744
[TBL] [Abstract][Full Text] [Related]
3. [Immune status against measles and rubella among 4 Chilean groups of different ages].
Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E
Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723
[TBL] [Abstract][Full Text] [Related]
4. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
Libman MD; Behr MA; Martel N; Ward BJ
Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility to measles, rubella and parotitis in young adults].
Bayas JM; Vilella A; Vidal J; Nebot X; Carbó JM; Navarro G; Prat A; Asenjo MA; Salleras L
Med Clin (Barc); 1996 Apr; 106(15):561-4. PubMed ID: 8656753
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey.
Wanlapakorn N; Wasitthankasem R; Vichaiwattana P; Auphimai C; Yoocharoen P; Vongpunsawad S; Poovorawan Y
PLoS One; 2019; 14(11):e0225606. PubMed ID: 31770412
[TBL] [Abstract][Full Text] [Related]
8. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
Oliveira J; da Cunha S; Côrte-Real R; Sampaio L; Dais N; Meliço-Silvestre A
Acta Med Port; 1995 Apr; 8(4):206-16. PubMed ID: 7625214
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
10. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
11. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran.
Doroudchi M; Dehaghani AS; Emad K; Ghaderi AA
East Mediterr Health J; 2001; 7(1-2):128-38. PubMed ID: 12596962
[TBL] [Abstract][Full Text] [Related]
13. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
[TBL] [Abstract][Full Text] [Related]
14. [Seroprevalence of rubella in Kinshasa (Zaire)].
Omanga U; Goussard B; Kapepela K; Bamba M; Salaun JJ; Piollet M
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):994-1001. PubMed ID: 1819439
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of rubella among Turkish women and children in Afyonkarahisar, Turkey.
Demirdal T; Demirtürk N; Toprak D; Aktepe OC; Aşci Z
Turk J Pediatr; 2009; 51(6):534-8. PubMed ID: 20196385
[TBL] [Abstract][Full Text] [Related]
17. Rubella antibodies in normal pregnant women at Srinagarind Hospital, Khon Kaen, Thailand.
Boonruang S; Buppasiri P
J Med Assoc Thai; 2005 Apr; 88(4):455-9. PubMed ID: 16146247
[TBL] [Abstract][Full Text] [Related]
18. Rubella and measles seroprevalence among women of childbearing age, Argentina, 2002.
Dayan GH; Panero MS; Urquiza A; Molina M; Prieto S; Del Carmen Perego M; Scagliotti G; Galimberti D; Carroli G; Wolff C; Bi D; Bellini W; Icenogle J; Reef S
Epidemiol Infect; 2005 Oct; 133(5):861-9. PubMed ID: 16181506
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of measles, rubella, and varicella in refugees.
Barnett ED; Christiansen D; Figueira M
Clin Infect Dis; 2002 Aug; 35(4):403-8. PubMed ID: 12145723
[TBL] [Abstract][Full Text] [Related]
20. Does rubella immunity predict measles immunity? A serosurvey of pregnant women.
Kennedy CM; Burns BA; Ault KA
Infect Dis Obstet Gynecol; 2006; 2006():13890. PubMed ID: 17485795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
